VYGR Robin Swartz sells $37K worth of shares
Dec 27, 2024, 11:32 AM
0.81%
What does VYGR do
Voyager Therapeutics, a clinical-stage gene therapy company based in Lexington, Massachusetts, focuses on developing treatments for severe neurological diseases, including Alzheimer's and ALS. Founded in 2015, it employs 162 people and utilizes its TRACER AAV platform for therapy development.
Robin Swartz sold 6,500 shares of VYGR on 23 December at $5.65 per share, worth a total of $37K. They now own 112,328 VYGR shares, or a 5% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.